Skip to main content
Fig. 1 | BMC Microbiology

Fig. 1

From: Comparative analysis of metagenomic next-generation sequencing for pathogenic identification in clinical body fluid samples

Fig. 1

Study overview and sample type composition. A total of 125 clinical body fluid samples were collected. Among these, thirty samples were used to compare cell-free DNA metagenomic next-generation sequencing (cfDNA mNGS) with whole-cell DNA metagenomic next-generation sequencing (wcDNA mNGS); forty-one samples were used to compare 16S rRNA gene NGS (16S rRNA NGS) with wcDNA mNGS; and all samples were used to evaluate the clinical performance of wcDNA mNGS was evaluated against culture results as a reference

Back to article page

BMC Microbiology

ISSN: 1471-2180

Contact us